Elias M. Oziolor

1. An industry perspective on the FDA Modernization Act 2.0/3.0: potential next steps for sponsors to reduce animal use in drug development
   2024/09/19 by Sarah A. Carratt, Christina L Zuch de Zafra, Elias M. Oziolor +4 · 1 voice
   Computer Science · Immunology and Microbiology · Veterinary · #Animal testing and alternatives #Computational Drug Discovery Methods #Immunotoxicology and immune responses